Key clinical point: A variety of demographic and disease-related factors contribute to poorer quality of life in patients with nonalcoholic fatty liver disease, most notably lobular inflammation.
Major finding: Multivariate analysis revealed an association between health-related quality of life and hepatic inflammation (P less than .05), but not fibrosis (P = .47).
Study details: A prospective quality of life study involving 304 patients with nonalcoholic fatty liver disease.
Disclosures: The study was funded by H2020. The investigators reported no conflicts of interest.
Huber Y et al. Clin Gastroenterol Hepatol. 2018 Dec 20. doi: 10.1016/j.cgh.2018.12.016.
This Week's Must Reads
Must Reads in Hepatology
Mortality Due to Cirrhosis & Liver Cancer in the US, BMJ; ePub 2018 Jul 18; Tapper, Parikh
Alpha Blockers & Treatment of Ureteric Stones, BMJ; ePub 2016 Dec 1; Hollingsworth, et al
FDA Approves Zepatier for Treatment of Chronic HCV, Genotypes 1 and 4 infections targeted